IF-MCT 16:8: Investigating the Influence of Intermittent Fasting With and Without MCTs in Patients With Drug-resistant Epilepsy

NARecruitingINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

July 25, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
EpilepsyIntermittent Fasting
Interventions
OTHER

IF 16:8 as active comparator vs. IF MCT 16:8 as experimental arm

12 weeks intermittent fasting according to the 16:8 method (IF 16:8) are compared with 12 weeks intermittent fasting with additional intake of exogenous MCTs (IF MCT 16:8) in a within-subject-crossover design in 28 patients with drug-resistant epilepsy. In order to enable the highest possible adherence, there are no restrictions on the composition of the food.

Trial Locations (1)

Baldingerstr., 35043

RECRUITING

Philipps University Marburg, Faculty of Medicine, Department of Neurology, Epilepsy Center, Marburg

All Listed Sponsors
lead

University Hospital Marburg

OTHER